Monday, May 25, 2026
No Result
View All Result
No Result
View All Result
No Result
View All Result

Oncotarget: Nanoparticle T cell engagers for the treatment of acute

Efficacy of nanoTCEs in vivo. (A) Tumor progression and (B) Kaplan-Meier survival comparison between mice treated with Isotype/CD3 (grey; n = 5) or CD33/CD3 nanoTCEs (green; n = 5)

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result

Bioengineer.org © Copyright 2023 All Rights Reserved.